An Adjuvant Made in Yeast Could Lower Vaccine Cost and Boost Availability

A natural molecule that boosts the effectiveness of vaccines is produced in small quantities by a single species of plant. A team led by Jay Keasling has successfully transferred the complicated, 38-gene synthesis pathway into yeast, opening the door for a large-scale, cost-saving manufacturing process of the molecule that is also less detrimental to the environment.

The post An Adjuvant Made in Yeast Could Lower Vaccine Cost and Boost Availability appeared first on Berkeley Lab News Center.

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks